Financial statements Nettle Pharma
Cash inflows of NETTLE PHARMA
Year
|
2021
|
2022
|
---|---|---|
Net cash from operating expenses | -456 582,87 | -413 750,80 |
Net cash flow from investing activities | 0,00 | 0,00 |
Net cash flow from financial activities | 600 000,00 | 286 327,53 |
Total net cash flow | 143 417,13 | -127 423,27 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.